Mandate

Vinge advises Advania’s shareholders in connection with the divestment to funds managed by Goldman Sachs

Vinge has advised the IT-provider company Advania with the divestment of a majority of the shares to funds managed by Goldman Sachs alongside management, VIA Equity and other reinvesting shareholders.

Today headquartered in Stockholm, Advania is a leading full-service IT-provider with a presence in all Nordic countries, delivering mission-critical IT solutions to meet every need.  Advania employs around 1,400 individuals in 27 locations in Sweden, Iceland, Norway, Finland and Denmark. Advania today has a turnover more than SEK 5bn, having delivered more than 20% growth each of the last five years. 

Goldman Sachs is a global leader in private equity, with a strong track record of investing in the technology sector and in the Nordics. To partner with them is not only a stamp of approval of what we have achieved so far but also a promise to everyone here at Advania that the journey ahead will be full of excitement and new possibilities. Most important is that we can stay true to our core ambition: to be a real partner to all customers and a great workplace that keeps on attracting the best talent, says Mikael Noaksson, Advania’s group CEO.

Vinge’s team consisted of Peter Sundgren, Joacim Rydergård, Samra Baytar, Elsie Nassar, Nina Gransäter and Gustav Persson (M&A), Axel Jansson and Rebecka Målquist (Banking and Finance), Jolene Reimerson and Mathilda Persson (Commercial Agreements), Sara Strandberg (Employment), Karl-Hugo Engdahl (IT & GDPR), Sofia Bergenstråhle (Intellectual Property), Karolina Cohrs (Real Property), John Wahlbom (Competition law), Tove Lövgren Frisk (Compliance) and Jessica Öijer and Nathalie Hughes (VDR).

Related

Vinge advises SAGA Diagnostics AB on convertible note issue

SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023

Vinge has advised private equity firm Stirling Square Capital Partners

Vinge has advised private equity firm Stirling Square Capital Partners in connection with its acquisition of a majority stake in Infobric, a leading provider of software solutions for the construction industry, from Summa Equity.
September 22, 2023